Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo (original) (raw)

References

  1. Liotta LA, Steeg PS and Stetler-Stevenson WG, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327–36.
    Article PubMed CAS Google Scholar
  2. Matrisian LM, 1992, The matrix-degrading metalloproteinases. Bioessays, 14, 455–63.
    Article PubMed CAS Google Scholar
  3. Woessner JF, 1991, Matrix metal loproteinases and their inhibitors in connective tissue remodeling. FASEB J, 5, 2145–54.
    PubMed CAS Google Scholar
  4. Nagase H, Ogata Y, Suzuki K, Enghild JJ and Salvensen G, 1991, Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem Soc Trans, 19, 715–18.
    PubMed CAS Google Scholar
  5. Sato H and Seiki M, 1993, Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8, 395–405.
    PubMed CAS Google Scholar
  6. Stetler-Stevenson WG, Krutzsch HC and Liotta LA, 1989, Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metallo-proteinase inhibitor family. J Biol Chem, 264, 17374–8.
    PubMed CAS Google Scholar
  7. Garbisa S, Ballin M, Daga-Gordini D, et al. 1986, Transient expression of type IV collagenolytic metalloproteinase by mononuclear phagocytes. J Biol Chem, 261, 2369–75.
    PubMed CAS Google Scholar
  8. Librach CL, Werb Z, Fitzgerald ML, et al. 1991, 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol, 113, 437–49.
    Article PubMed CAS Google Scholar
  9. Salo T, Turpeenniemi-Hujanen T and Tryggvason K, 1985, Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloprotease by human fibroblasts. J Biol Chem, 260, 8526–31.
    PubMed CAS Google Scholar
  10. Salo T, Liotta LA, Keski J, Turpeenniemi-Hujanen T and Tryggvason K, 1982, Secretion of basement membrane collagen degradation enzyme and plasminogen activator by transformed cells—Role in metastasis. Int J Cancer, 30, 669–73.
    PubMed CAS Google Scholar
  11. Schultz RM, Silberman S, Persky B, Bajkoski AS and Carmichael DF, 1988, Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res, 48, 5539–45.
    PubMed CAS Google Scholar
  12. Hibbs MS, Hoidal JR and Kang AH, 1987, Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest, 80, 1644–50.
    PubMed CAS Google Scholar
  13. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI and Welgus HG, 1991, Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem, 266, 7870–5.
    PubMed CAS Google Scholar
  14. Liotta LA and Stetler-Stevenson WG, 1990, Metalloproteinases and cancer invasion. Semin Cancer Biol, 1, 99–106.
    PubMed CAS Google Scholar
  15. Stearns ME and Wang M, 1993, Type IV collagenase (M r 72,000) expression in human prostate: benign and malignant tissue. Cancer Res, 53, 878–83.
    PubMed CAS Google Scholar
  16. Pyke C, Ralfkiaer E, Tryggvason K and Danø K, 1993, Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol, 142, 359–65.
    PubMed CAS Google Scholar
  17. Monteagudo C, Merino MJ, San-Juan J, Liotta LA and Stetler-Stevenson WG, 1990, Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol, 136, 585–92.
    PubMed CAS Google Scholar
  18. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Danø K and Tryggvason K, 1992, Localization of messenger RNA for M r 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res, 52, 1336–41.
    PubMed CAS Google Scholar
  19. Templeton NS and Stetler-Stevenson WG, 1991, Identification of a basal promotor for the human M r 72,000 type IV collagenase gene and enhanced expression in a highly metastasic cell line. Cancer Res, 51, 6190–3.
    PubMed CAS Google Scholar
  20. Russel DC and Rubinstain LJ, 1989, Pathology of Tumors of the Nervous System, 5th edn. London: Edward Arnold, pp. 1–50.
    Google Scholar
  21. Gleave JR, 1986, Surgery for primary brain tumors. In: Blehen NM, ed. Tumors of the Brain. Berlin: Springer-Verlag, pp. 101–20.
    Google Scholar
  22. Yamamoto M, Sawaya R, Mohanam S, et al. 1994, Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res, 54, 3654–61.
    Google Scholar
  23. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA and Sawaya R, 1993, Elevated levels of M r 92,000 type IV collagenase in human brain tumors. Cancer Res, 53, 2208–11.
    PubMed CAS Google Scholar
  24. Robson DK, Ironside JW, Reid WA and Bogue PR, 1990, Immunolocalization of cathepsin D in the human central nervous system and central nervous system neoplasms. Neuropathol Appl Neurobiol, 16, 39–44.
    PubMed CAS Google Scholar
  25. Kleihues P, Burger PC and Scheithauer BW, 1993, The new WHO classification of brain tumours. Brain Pathol, 3, 255–68.
    PubMed CAS Google Scholar
  26. Juarez J, Clayman G, Nakajima M, et al. 1993, Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous cell-carcinoma cell lines of the oral cavity. Int J Cancer, 55, 10–18.
    PubMed CAS Google Scholar
  27. Chomczynski P and Sacchi N, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Analyt Biochem, 162, 156–9.
    Article PubMed CAS Google Scholar
  28. Jin L, Nakajima M and Nicolson GL, 1990, Immunochemical localization of heparanase in mouse and human melanoma metastases. Int J Cancer, 45, 1088–95.
    PubMed CAS Google Scholar
  29. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE and Turner DR, 1991, Distribution of collagenase and tissue inhibitor of metallo-proteases (TIMP) in colorectal tumors. Int J Cancer, 49, 666–72.
    PubMed CAS Google Scholar
  30. Apodaca G, Rutka JT, Bouhana K, et al. 1990, Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res, 50, 2322–9.
    PubMed CAS Google Scholar
  31. Reith A and Rucklidge GJ, 1992, Invasion of brain tissue by primary glioma: evidence for the involvement of urokinase-type plasminogen activator as an activator of type IV collagenase. Biochem Biophys Res Commun, 186, 348–54.
    Article PubMed CAS Google Scholar
  32. Rao JS, Steck PA, Tofilon P, et al. 1994, Role of plasminogen activator and of 92 kDa type IV collagenase in glioblastoma invasion using an in vitro Matrigel model. J Neuro-Oncol, 18, 129–38.
    Article CAS Google Scholar
  33. Nakagawa T, Kubota T, Kubota M, et al. 1994, Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg, 81, 69–77.
    PubMed CAS Google Scholar
  34. Bjerkvig R, Laerum OD and Mella O, 1986, Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res, 46, 4071–9.
    PubMed CAS Google Scholar
  35. Sato H, Takino T, Okada Y, et al. 1994, A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature, 370, 61–5.
    Article PubMed CAS Google Scholar
  36. Folkman J, Watson K, Ingber D and Hanahan D, 1989, Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature, 339, 8–61.
    Article Google Scholar
  37. Goldfarb RH, Ziche M, Murano G and Liotta LA, 1986, Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesis. Semin Thromb Hemostasis, 12, 337–8.
    CAS Google Scholar

Download references